Molecular Characteristics
Complete Specifications
Structural Composition
Modified 37-amino-acid human amylin analog with acylation and strategic substitutions to enhance stability and receptor interaction
Physical Properties
Cagrilintide is a synthetic 37-amino-acid peptide engineered as a long-acting amylin analog. Structural modifications, including targeted amino acid substitutions and lipidation (acylation), enhance molecular stability and extend structural persistence under controlled research conditions. The presence of disulfide linkages contributes to conformational stability, while lyophilized formulation supports extended shelf stability when protected from light, moisture, and repeated freeze–thaw cycles. Proper cold storage preserves peptide integrity for laboratory and analytical applications.
Research Applications
Appetite Regulation and Satiety Signaling Research
Cagrilintide is utilized as a research compound in studies examining appetite regulation and amylin receptor signaling pathways. Laboratory investigations focus on its role in:
- Amylin Receptor Activation Models: Investigation of receptor binding dynamics and downstream signaling cascades
- Satiety Signaling Pathways: Evaluation of neuroendocrine mechanisms involved in hunger and fullness regulation
- Gastric Emptying Modulation Studies: Analysis of signaling mechanisms influencing gastric motility in experimental models
- Hypothalamic Activity Research: Examination of central pathways involved in energy intake regulation
- Neurohormonal Communication: Investigation of peptide-mediated cross-talk between peripheral and central systems
Experimental protocols commonly employ receptor-binding assays, neuronal signaling models, and metabolic behavior studies to characterize Cagrilintide-mediated satiety signaling.
Metabolic and Energy Balance Research
Cagrilintide has been extensively studied in research models related to metabolic regulation and body mass dynamics. Key areas of investigation include:
- Energy Intake Regulation Models: Evaluation of feeding behavior and caloric consumption patterns under experimental conditions
- Body Weight Signaling Pathways: Investigation of hormonal signaling influencing energy storage and expenditure
- Glucose and Lipid Interaction Studies: Research into metabolic cross-regulation between carbohydrate and lipid pathways
- Insulin and Amylin Co-Signaling Models: Analysis of coordinated peptide signaling in metabolic systems
- Long-Term Energy Adaptation Research: Examination of sustained metabolic responses to altered satiety signaling
This body of research utilizes metabolic monitoring assays, endocrine profiling, and longitudinal experimental models to assess systemic energy balance effects.
Gastrointestinal and Endocrine Signaling Research
Cagrilintide has also been explored in studies focusing on gastrointestinal and endocrine communication systems, including:
- Gut–Brain Axis Models: Evaluation of signaling interactions between gastrointestinal peptides and central appetite centers
- Hormonal Release Regulation: Investigation of endocrine responses associated with nutrient intake
- Receptor Selectivity and Binding Studies: Research into amylin receptor subtype specificity
- Signal Integration Pathways: Examination of coordinated metabolic signaling networks
Laboratory protocols assess receptor activation, hormonal response patterns, and gastrointestinal signaling activity using biochemical and cellular assays.
Cellular Signaling and Metabolic Stress Research
Additional research applications explore Cagrilintide’s influence on intracellular signaling pathways involved in metabolic stress and adaptation, including:
- cAMP and Downstream Signaling Cascades: Investigation of intracellular responses following receptor engagement
- Neuroendocrine Adaptation Models: Analysis of central and peripheral adaptation to sustained signaling modulation
- Inflammatory and Stress Marker Studies: Research into secondary signaling responses associated with metabolic modulation
- Cellular Homeostasis Maintenance: Examination of regulatory mechanisms preserving metabolic equilibrium
Research in this domain focuses on understanding how Cagrilintide influences amylin receptor signaling, appetite regulation pathways, and systemic metabolic adaptation under controlled experimental conditions.
Laboratory Handling and Storage Protocols
Lyophilized Powder Storage
- Store at –20°C to –80°C in the original, sealed vial
- Protect from light exposure and moisture
- A desiccated storage environment is recommended
- Stability data suggests extended stability when stored at −20 °C or below.
Reconstituted Solution Storage
- Short-term storage: Up to 7 days at 4°C
- Long-term storage: Store at –20°C in aliquots
- Use single-use aliquots to preserve peptide integrity
- Minimize freeze–thaw cycles; single-use aliquots are strongly recommended
Stability Characteristics
Cagrilintide is a synthetic peptide research compound that demonstrates good stability under controlled laboratory conditions. Maintaining appropriate cold storage of the lyophilized material, minimizing mechanical agitation during reconstitution, and limiting freeze–thaw exposure help preserve structural integrity and solubility. When handled according to standard peptide protocols, Cagrilintide supports consistent use in in vitro and analytical research applications.
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a synthetic amylin receptor agonist engineered for extended activity in experimental models. It is used in laboratory research to study metabolic signaling, satiety pathways, and receptor activation dynamics.
What is Cagrilintide commonly researched for?
In preclinical and laboratory settings, Cagrilintide is studied for:
-
Amylin receptor signaling
-
Appetite-regulation pathway models
-
Glucose and metabolic regulation mechanisms
-
Combination pathway research involving metabolic peptides
All research applications are exploratory and conducted in controlled environments.
How does Cagrilintide differ from native amylin?
Cagrilintide is structurally modified to provide enhanced stability and extended activity compared to native amylin in research models. These modifications may influence receptor affinity and pharmacokinetic behavior in preclinical studies.
Is Cagrilintide the same as GLP-1 receptor agonists?
No. Cagrilintide primarily targets amylin and calcitonin receptor pathways, whereas GLP-1 receptor agonists act on the GLP-1 receptor. While both are studied in metabolic research, their mechanisms of action differ.
How is Cagrilintide supplied?
Cagrilintide is typically supplied as a lyophilized (freeze-dried) powder in sealed research vials. This form supports stability during storage and transport prior to laboratory preparation.
How should unreconstituted Cagrilintide be stored?
Lyophilized Cagrilintide should be stored:
-
Long-term: −20 °C to −80 °C
-
Short-term: 2–8 °C
Vials should remain sealed and protected from light and moisture.
How should reconstituted Cagrilintide be handled and stored?
Once reconstituted:
-
Store at 2–8 °C for short-term laboratory use
-
For extended storage, aliquot and freeze at −20 °C or below
-
Minimize freeze–thaw cycles using single-use aliquots
-
Gently swirl to mix; avoid vigorous agitation
Is Cagrilintide FDA-approved?
Cagrilintide is not FDA-approved as a research compound for human consumption. When sold for laboratory use, it must not be marketed or used for diagnostic, therapeutic, or consumption purposes.
Does Cagrilintide require a Certificate of Analysis (COA)?
Yes. A Certificate of Analysis (COA) should be available for each batch, verifying peptide identity, purity, and analytical testing results to ensure research quality and traceability.
This product is not for human consumption. It is sold strictly for research and educational purposes and is not intended to diagnose, treat, cure, or prevent any disease.
Any clinical data or research information referenced on this page is derived from peer-reviewed scientific literature and official publications. This information is provided for educational reference only and does not constitute medical advice or product claims.
By purchasing this product, you acknowledge that you are a qualified researcher and agree to use it in full compliance with all applicable laws and regulations.
